Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights ...
Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...
AI and genetics are creating a 'seismic shift' in the pharmaceutical business, experts on Asian Financial Forum panel say ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results